3 Dividend Stocks to Double Up On Right Now

5.7%: Enterprise Products Partners yields 5.7%, with distributable cash flow covering the distribution by ~1.7x, 27 consecutive annual distribution increases, fee-based energy infrastructure that limits commodity-price exposure, and an investment-grade balance sheet. Realty Income yields 5.2%, has increased dividends for 31 consecutive years, an adjusted FFO payout ratio of ~75%, investment-grade credit and dominant net-lease scale that supports capital access. Medtronic yields 3.2% with 48 consecutive years of dividend growth (two years from Dividend King); a planned diabetes spinoff and new Hugo surgical-robot products could drive higher profitability and valuation upside. The article positions these stocks as defensive, income-oriented buys amid geopolitical and inflation uncertainty and suggests buying or adding for long-term income.

Analysis

Midstream (EPD) is being priced more as a volume/contract story than a commodity call; the real optionality is on structurally higher takeaway and export capacity from the Permian and US Gulf Coast. If power generation and LNG demand remain elevated through the next 12–36 months, fee-based throughput could absorb downside from crude price swings and drive modest multiple expansion — conversely, capex pullbacks by E&P players would show up in volumes within 6–12 months and are the primary downside trigger.

Realty Income’s dynamics are a function of cap-rate direction more than retail occupancy in the near term. A sustained Fed pivot would likely compress cap rates and re-rate the name materially within 6–18 months; if rates persist or credit spreads widen another 50–100bps, the downside will be driven by refinancing cliff risk on smaller tenants rather than headline FFO coverage.

Medtronic’s spin-off is the clearest binary: the market tends to underpay for deconglomeration optionality until the first two post-spin quarters reveal free cash flow reallocation plans. The surgical-robot market is a multi-year adoption curve; meaningful upside requires 18–36 months for installed-base growth, reimbursement clarity, and evidence of margin leverage — failure to hit unit targets would slow valuation rerating and could prompt buyback conservatism.

Key Decisions for Investors

• Long EPD (2–4% portfolio) with a 12–36 month horizon; buy the stock and hedge tail risk with a 12-month 15–20% OTM put (cost ~1–3% of position). R/R: steady distribution + possible multiple expansion vs ~15–20% downside protected by the put premium.
• Relative-value pair: long EPD vs short commodity-sensitive E&P name (size 1–2% net) for 6–12 months to isolate fee-based cashflow vs spot-exposed producers. R/R: captures basis compression if midstream volumes hold; risk is systemic oil shock boosting both legs.
• Event trade on MDT: buy MDT (1–3% portfolio) into the spin-off window and purchase 18–24 month 10–15% OTM calls as a leveraged upside ticket. R/R: limited cash outlay for asymmetric upside if FCF redeployment/buybacks are announced; risk is slower robotic adoption or disappointing spin-off cash flows.
• Income tactical on O: sell 6–9 month 8–12% OTM puts to collect premium (size 1–2% capital); deploy only if willing to own at strike. R/R: enhances yield if rates stabilize; risk is material cap-rate widening leading to mark-to-market losses and assignment.